These stubborn areas are characterized by several factors including high alpha-2 adrenergic receptor density relative to beta receptors, reduced blood flow, and greater insulin sensitivity leading to efficient fat storage
As a research compound, long-term human data is still being gathered, but preclinical models and existing evidence suggest it is well-tolerated when used appropriately
Scientific References Kraus D, Yang Q, Kong D, et al
Most users don't see dramatic overnight changes but appreciate the steady support it offers when paired with the basics of good health
Unwilling to accept a compound with zero published human safety data of any kind
For maintenance in chronic conditions, monthly injections are typical